ReviewTherapeutic advances in medical oncology2021

The progress and challenge of anti-PD-1/PD-L1 immunotherapy in treating non-small cell lung cancer.

Jingjing Qu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.